The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Garner William J since 2009.
The trader's CIK number is 1407235.
At the time of the last reporting, Garner William J was the Chief Executive Offi of Delmar Pharmaceuticals, Inc.. (stock ticker symbol DMPI).
Also see all insider trading activities at Delmar Pharmaceuticals, Inc..
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2015 | DMPI | 16,666 | $9,999 | 0 | $0 | 0 | $0 |
2014 | DMPI | 0 | $0 | 80,000 | $104,000 | 0 | $0 |
2013 | DMPI | 5,000 | $5,000 | 0 | $0 | 0 | $0 |
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2009 | UGRP.OB | 110,800 | $10,008 | 0 | $0 | 0 | $0 |
1. Delmar Pharmaceuticals, Inc. (DMPI)
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2015-07-16 | DMPI | Buy | 16,666 | .60 | 9,999 |
2014-03-18 | DMPI | Sale | 80,000 | 1.30 | 104,000 |
2013-09-20 | DMPI | Buy | 5,000 | 1.00 | 5,000 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2009-03-13 | UGRP.OB | Buy | 1,000 | .09 | 90 |
2009-03-13 | UGRP.OB | Buy | 1,000 | .09 | 90 |
2009-03-11 | UGRP.OB | Buy | 1,000 | .09 | 90 |
2009-03-05 | UGRP.OB | Buy | 5,000 | .08 | 400 |
2009-02-25 | UGRP.OB | Buy | 1,000 | .10 | 100 |
2009-01-29 | UGRP.OB | Buy | 16,000 | .15 | 2,400 |
2009-01-30 | UGRP.OB | Buy | 17,800 | .14 | 2,403 |
2009-01-26 | UGRP.OB | Buy | 5,000 | .17 | 850 |
2009-01-27 | UGRP.OB | Buy | 10,000 | .12 | 1,200 |
2009-01-21 | UGRP.OB | Buy | 48,000 | .04 | 2,160 |
2009-01-20 | UGRP.OB | Buy | 5,000 | .04 | 225 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Garner William J (Chief Executive Offi of Delmar Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.